Aps (Metformin Hydrochloride, Sitagliptin)

Aps combines Metformin Hydrochloride and Sitagliptin for oral use, aiding blood sugar management. This medication is commonly used in diabetes care to support glucose control.

Aps is typically used to manage type 2 diabetes. It combines two active ingredients, Metformin Hydrochloride and Sitagliptin, which work together to help control blood sugar levels. This medication is often prescribed for individuals who require dual therapy to achieve optimal glucose management.

Common effects of Aps may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Aps should be handled with care, especially for individuals with kidney or liver issues. It is important to follow the prescribed dosage and administration instructions. Regular monitoring of blood sugar levels is recommended while using this medication. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Aps may interact with certain medications, including those that affect kidney function or other diabetes treatments. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while using Aps.